Carbon Monoxide Diffusing Capacity (DL CO ) Correlates with CT Morphology after Chemo-Radio-Immunotherapy for Non-Small Cell Lung Cancer Stage III.
Markus StanaBrane GrambozovChristoph GaisbergerJosef KarnerElvis RuznicJohannes BerchtoldBarbara ZellingerRaphaela MoosbruggerMichael StudnickaGerd FastnerFelix SedlmayerFranz ZehentmayrPublished in: Diagnostics (Basel, Switzerland) (2022)
The current analysis revealed a strong relation between the dynamics of DLCO and CT morphology changes in the mid-dose range, which convincingly indicates the importance of routinely used PFTs in the context of a curative treatment approach.